PORTA, FEDERICA

PORTA, FEDERICA  

Dipartimento di Scienze Farmaceutiche  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL ANTIPROLIFERATIVE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS 27-feb-2017 F. Porta Doctoral Thesis -
Development of novel substituted naphthyl amino benzoic acid derivatives as CDC25 phosphatase inhibitors: design, synthesis and biological evaluation 1-lug-2015 F. PortaA. GelainS. Villa + Conference Object -
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 1-gen-2019 Gelain, AriannaMori, MatteoMeneghetti, FiorellaPorta, FedericaVilla, Stefania + Article (author) -
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 1-nov-2017 F. PortaA. GelainD. BarloccoN. FerriS. Marchiano'V. CappelloF. MeneghettiS. Villa + Article (author) -
Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach 1-dic-2016 A. GelainF. Porta + Article (author) -
Identification of a novel STAT3 inhibitor structurally related to the oxadiazole derivative MD77 1-set-2013 D. MasciocchiS. VillaF. PortaD. BarloccoF. MeneghettiA. Gelain + Conference Object -
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 5-mag-2017 F. PortaG. FacchettiA. GelainF. MeneghettiS. VillaD. BarloccoD. MasciocchiS. MarchianòI. Rimoldi + Article (author) -
Methanethiosulfonate derivatives as ligands of STAT3-SH2 domain 1-giu-2014 E. GabrieleA. BarteselliF. PortaA. GelainA. Sparatore + Conference Object -
Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB) : from Biological Insight to Inhibitors 1-ott-2015 FANZANI, LUISAF. PortaF. MeneghettiS. VillaA. Gelain + Article (author) -
New 1,2,5-oxadiazole Pt(II)complex endowed with STAT3 inhibitory properties as promising anticancer agent 1-giu-2017 A. GelainS. VillaF. MeneghettiF. PortaG. FacchettiI. Rimoldi + Article (author) -
New Platinum(II) complexes in STAT3 inhibition: a promising tool for anticancer therapy 2-set-2015 I. RimoldiF. PortaS. VillaA. GelainF. MeneghettiD. BarloccoN. FerriG. Facchetti + Book Part (author) -
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 28-ott-2016 F. PortaG. FacchettiS. VillaA. GelainF. MeneghettiD. BarloccoI. Rimoldi + Book Part (author) -
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 23-ott-2015 G. FacchettiF. PortaS. VillaA. GelainF. MeneghettiD. BarloccoI. Rimoldi + Book Part (author) -
STAT3 direct inhibitors: from MD77 to AC33 1-lug-2015 F. PortaS. VillaA. GelainD. BarloccoI. RimoldiG. FacchettiN. Ferri + Conference Object -
Sviluppo di MD77: nuovi derivati eterociclici inibenti STAT3 1-set-2014 A. GelainF. PortaS. Dell’OrtoS. VillaD. MasciocchiD. BarloccoF. MeneghettiN. Ferri + Book Part (author) -
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 1-gen-2017 E. GabrieleF. PortaG. FacchettiC. GalliA. GelainF. MeneghettiI. RimoldiS. RomeoS. VillaC. RicciD. BarloccoA. Sparatore + Article (author) -
Synthesis, structure-activity relationships and stereochemical investigations on new tricyclic pyridazinone derivatives as potential STAT3 inhibitors 1-gen-2013 F. MeneghettiD. MasciocchiA. GelainF. PortaA. PedrettiG. CelentanoD. BarloccoS. Villa + Conference Object -
Synthesis, structure–activity relationships andstereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors 1-gen-2013 D. MasciocchiA. GelainF. PortaF. MeneghettiA. PedrettiG. CelentanoD. BarloccoL. LegnaniS. Villa + Article (author) -